Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.048 AUD | +4.35% | +23.08% | +118.18% |
Apr. 09 | Anatara Lifesciences Begins Recruitment for Irritable Bowel Syndrome Stage Two Trial | MT |
Feb. 28 | Anatara Lifesciences Ltd Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+118.18% | 5.26M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- ANR Stock
- News Anatara Lifesciences Ltd
- Anatara Lifesciences to Proceed to Stage II of IBS Drug Trial